Suchergebnisse - "Zhou, Yangzhong"

PubPharm (95)

11

The prevalence of burnout among pulmonologists or respiratory therapists pre- and post-COVID-19 : a systematic review and meta-analysis

enthalten in: Annals of medicine | 2023

von Bai, X. | Wan, Z. | Tang, J. | +10

12

Tacrolimus shows adequate efficacy in patients with antiphospholipid antibodies associated thrombocytopenia : a retrospective cohort study

enthalten in: Clinical and experimental medicine | 2023

von Shi, Y. | Huang, C. | Zhou, Y. | +5

13

Associations of low-carbohydrate with mortality in chronic kidney disease

enthalten in: Renal failure | 2023

von Ren, Q. | Zhou, Y. | Luo, H. | +5

14

Tacrolimus shows adequate efficacy in patients with antiphospholipid antibodies associated thrombocytopenia: a retrospective cohort study

enthalten in: Clinical and experimental medicine | 2023

von Shi, Y. | Huang, C. | Zhou, Y. | +5

15

Serum Calprotectin as a Potential Predictor of Microvascular Manifestations in Patients with Antiphospholipid Syndrome

enthalten in: Rheumatology and therapy | 2023

von Zhao, Y. | Qi, W. | Huang, C. | +7

16

Cluster analysis of antiphospholipid antibodies-associated adverse pregnancy outcome patients: based on a 13-years cohort study

enthalten in: Clinical and experimental medicine | 2023

von Long, Y. | Huang, C. | Cui, Y. | +10

17

Anti-β2GPI-domain I antibody is associated with extra-criteria manifestations in a large prospective antiphospholipid syndrome cohort in China

enthalten in: Lupus science & medicine | 2023

von Zhou, Y. | Hu, C. | Qi, W. | +7

18

Comparative Efficacy of Secukinumab Versus Tumor Necrosis Factor Inhibitors for the Treatment of Takayasu Arteritis

enthalten in: Arthritis & rheumatology (Hoboken, N.J.) | 2023

von Tian, X. | Li, M. | Jiang, N. | +10

CommentIn: Arthritis Rheumatol. 2023 Oct;75(10):1871. - PMID 37067761

19

Validation of three prediction models for thrombosis recurrence in antiphospholipid syndrome patients based on a prospective cohort

enthalten in: RMD open | 2023

von Zhao, Y. | Huang, C. | Qi, W. | +7

20

Do intravitreal anti-vascular endothelial growth factor agents lead to renal adverse events? A pharmacovigilance real-world study

enthalten in: Frontiers in medicine | 2023

von Jiang, L. | Peng, L. | Zhou, Y. | +4